Your browser doesn't support javascript.
loading
Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours.
Cierna, Zuzana; Miskovska, Vera; Roska, Jan; Jurkovicova, Dana; Pulzova, Lucia Borszekova; Sestakova, Zuzana; Hurbanova, Lenka; Machalekova, Katarina; Chovanec, Michal; Rejlekova, Katarina; Svetlovska, Daniela; Kalavska, Katarina; Kajo, Karol; Babal, Pavel; Mardiak, Jozef; Ward, Thomas A; Mego, Michal; Chovanec, Miroslav.
Afiliación
  • Cierna Z; Department of Pathology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
  • Miskovska V; 1st Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
  • Roska J; St. Elisabeth Cancer Institute, Bratislava, Slovakia.
  • Jurkovicova D; Department of Genetics, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Pulzova LB; Department of Genetics, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Sestakova Z; Department of Genetics, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Hurbanova L; Department of Genetics, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Machalekova K; Department of Genetics, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Chovanec M; St. Elisabeth Cancer Institute, Bratislava, Slovakia.
  • Rejlekova K; 2nd Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
  • Svetlovska D; National Cancer Institute, Bratislava, Slovakia.
  • Kalavska K; St. Elisabeth Cancer Institute, Bratislava, Slovakia.
  • Kajo K; 2nd Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
  • Babal P; St. Elisabeth Cancer Institute, Bratislava, Slovakia.
  • Mardiak J; Translational Research Unit, Comenius University, Bratislava, Slovakia.
  • Ward TA; St. Elisabeth Cancer Institute, Bratislava, Slovakia.
  • Mego M; Translational Research Unit, Comenius University, Bratislava, Slovakia.
  • Chovanec M; Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center, University Science Park for Biomedicine, Slovak Academy of Sciences, Bratislava, Slovakia.
BMC Cancer ; 20(1): 17, 2020 Jan 06.
Article en En | MEDLINE | ID: mdl-31906898
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Testiculares / Cisplatino / Neoplasias de Células Germinales y Embrionarias / Reparación del ADN / Proteína de la Xerodermia Pigmentosa del Grupo A / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Eslovaquia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Testiculares / Cisplatino / Neoplasias de Células Germinales y Embrionarias / Reparación del ADN / Proteína de la Xerodermia Pigmentosa del Grupo A / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Eslovaquia Pais de publicación: Reino Unido